Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial-Reference-Cited by-同舟云学术

Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial

Published:2019-07-16 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hyakuna Nobuyuki¹^ORCID,Hashii Yoshiko²,Ishida Hiroyuki³,Umeda Katsutsugu⁴^ORCID,Takahashi Yoshiyuki⁵,Nagasawa Masayuki⁶,Yabe Hiromasa⁷,Nakazawa Yozo⁸^ORCID,Koh Katsuyoshi⁹,Goto Hiroaki¹⁰,Fujisaki Hiroyuki¹¹,Matsumoto Kimikazu¹²^ORCID,Kakuda Harumi¹³,Yano Michihiro¹⁴,Tawa Akio¹⁵,Tomizawa Daisuke¹²^ORCID,Taga Takashi¹⁶^ORCID,Adachi Souichi¹⁷,Kato Koji¹⁸

Affiliation:

1. Department of PediatricsUniversity of the Ryukyus Hospital Nishihara Japan

2. Department of PediatricsOsaka Graduate School of Medicine Osaka Japan

3. Department of PediatricsKyoto City Hospital Kyoto Japan

4. Department of Pediatrics, Graduate School of MedicineKyoto University Kyoto Japan

5. Department of PediatricsNagoya University Graduate School of Medicine Nagoya Japan

6. Department of PediatricsMusashino Red Cross Hospital Musashino Japan

7. Department of Cell Transplantation and Regenerative MedicineTokai University School of Medicine Isehara Japan

8. Department of PediatricsShinshu University School of Medicine Matsumoto Japan

9. Department of Hematology and OncologySaitama Children's Medical Center Saitama Japan

10. Division of Hematology/OncologyKanagawa Children's Medical Center Yokohama Japan

11. Department of Pediatric Hematology and OncologyOsaka City General Hospital Osaka Japan

12. Children's Cancer CenterNational Center for Child Health and Development Tokyo Japan

13. Department of Hematology/OncologyChiba Children's Hospital Chiba Japan

14. Department of PediatricsAkita University Hospital Akita Japan

15. Higashiosaka Aramoto Heiwa Clinic Higashiosaka Japan

16. Department of PediatricsShiga University of Medical Science Ōtsu Japan

17. Department of Human Health SciencesKyoto University Kyoto Japan

18. Department of Hematology and OncologyChildren's Medical Center, Japanese Red Cross Nagoya First Hospital Nagoya Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27875

Reference28 articles.

1. Biology, risk stratification, and therapy of pediatric acute leukemias: an update;Pui CH;J Clin Oncol,2011

2. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel;Creutzig U;Blood,2012

3. Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia;Song TY;Blood Res,2018

4. Pediatric acute myeloid leukemia;Kaspers GJ;Expert Rev Anticancer Ther,2012

5. Frequency of prolonged remission duration after high‐dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield CD;Cancer Res,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia/Lymphoma Study Group;Transplantation and Cellular Therapy;2024-08

2. Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data;Annals of Hematology;2023-04-15

3. Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data;Annals of Hematology;2023-03-06

4. Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study;Frontiers in Oncology;2023-02-09

5. Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis;Annals of Hematology;2022-08-30